Intervention
Acetazolamide
ClinicalTrials.gov intervention label
Clinical trials
34 shownAdd-on Diuretics in Acute Decompensated Heart FailureNCT07372040 · 2026-02-01
RECRUITINGVenous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term AcetazolamideNCT06945848 · 2026-01-05
RECRUITINGComparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart FailureNCT07199088 · 2025-10-11
RECRUITINGOptimal Diuretic Therapies for Acute Heart Failure With Volume OverloadNCT06166654 · 2024-09-05
RECRUITINGAcetazolamide in Persons With Type 1 Diabetes - Crossover TrialNCT06981234 · 2024-08-14
RECRUITINGAcetazolamide Per os for Decompensation of Heart FailureNCT05802849 · 2023-05-01
RECRUITINGAcetazolamide for Treatment Resistant SchizophreniaNCT04887792 · 2022-02-01
RECRUITINGACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.NCT07737964 · 2026-10-01
NOT_YET_RECRUITINGAcetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure PatientsNCT06535529 · 2024-08-24
UNKNOWNEfficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume OverloadNCT06414759 · 2024-07-01
UNKNOWNCarbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda ConsumptionNCT06110078 · 2024-01-18
UNKNOWNEfficacy of Oral Acetazolamide in Decongestion in Patients With Heart FailureNCT05940220 · 2023-12-30
UNKNOWNDiuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic ResistanceNCT05986773 · 2023-10-10
TERMINATEDAcetazolamide in Persons With Type 1 Diabetes - Dose FindingNCT05473364 · 2023-03-20
COMPLETEDAcetazolamide to Prevent Impending Altitude-illness in Patients With COPDNCT04913389 · 2021-06-01
UNKNOWNEffect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High AltitudeNCT04915365 · 2021-05-01
UNKNOWNSurgical Idiopathic Intracranial Hypertension Treatment TrialNCT03501966 · 2019-02-06
TERMINATEDAcetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)NCT03505788 · 2018-11-11
COMPLETEDAcetazolamide in Patients With Acute Heart FailureNCT03720288 · 2018-10-01
UNKNOWNImpact of Acetazolamide in Reducing Referred Postoperative PainNCT04470843 · 2018-08-22
COMPLETEDAcute Hemodynamic Effect of Acetazolamide in Pulmonary HypertensionNCT02755259 · 2017-01-01
COMPLETEDChronic Clinical Effect of AcetazolamideNCT02755298 · 2016-10-01
COMPLETEDAugmenting Cerebral Blood Flow to Treat Established Multiple SclerosisNCT02466074 · 2016-08-17
TERMINATEDAZ, MZ, and the Pulmonary System Response to HypoxiaNCT02760121 · 2016-05-01
COMPLETEDEffect of Acetazolamide on Optic Nerve Sheath Diameter in Laparoscopic Donor NephrectomiesNCT03005665 · 2016-02-01
COMPLETEDStop Retinal Ganglion Cell Dysfunction StudyNCT02390284 · 2015-09-01
TERMINATEDA Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular DysfunctionNCT02220803 · 2014-03-01
COMPLETEDTreatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.NCT01499485 · 2011-11-01
COMPLETEDEffectiveness of Acetazolamide for Reversal of Metabolic Alkalosis in Mechanically Ventilated Chronic Obstructive Pulmonary Disease PatientsNCT01627639 · 2011-10-01
COMPLETEDPredicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure PatientsNCT01377987 · 2011-08-01
COMPLETEDIdiopathic Intracranial Hypertension Treatment TrialNCT01003639 · 2010-01-01
COMPLETEDBuspirone as a Potential Treatment for Recurrent Central ApneaNCT00746954 · 2008-09-01
TERMINATEDOral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal BevacizumabNCT00864838 · 2008-06-01
COMPLETEDImmediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - ClosureNCT01923454 · 2005-12-01
COMPLETEDCommon conditions
Acute Decompensated Heart Failure5Heart Failure4Acute Heart Failure3Altitude Sickness3Hypertension, Pulmonary3Chronic Obstructive Pulmonary Disease2Idiopathic Intracranial Hypertension2Type 1 Diabetes2Volume Overload2Age Related Macular Degeneration1Altitude Hypoxia1Blood Pressure1Central Apnea1Chronic Heart Failure1Decompensated Chronic Obstructive Pulmonary Disease1Diabetic Retinopathy1Diuretic Resistance1Edema1Glaucoma1Glaucoma, Angle-closure1Heart Failure, Diastolic1Heart Failure, Systolic1Heart Failures1Hypertension1Idiopathic Intracranial Hypertension (IIH)1
Leading sponsors
University of Zurich4University Hospital, Montpellier2University of California, San Diego2Assistance Publique - Hôpitaux de Paris1Cairo University1David Andrew Wellman1Göteborg University1Helwan University1Hospital Son Llatzer1Jaeb Center for Health Research1Johannes Grand1Medical College of Wisconsin1Post Graduate Institute of Medical Education and Research, Chandigarh1Samara State Medical University1Siriraj Hospital1
Trial status mix
COMPLETED14
RECRUITING7
UNKNOWN7
TERMINATED5
NOT_YET_RECRUITING1
Phase mix
PHASE313
PHASE210
PHASE47
NA5
PHASE13
EARLY_PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.